Evaluation of the therapeutic potential of carbonic anhydrase inhibitors in two animal models of dystrophin deficient muscular dystrophy

A thiabendazole sulfonamide shows potent inhibitory activity against mammalian and nematode α-carbonic anhydrases

(2009) Letizia Crocetti et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Caenorhabditis elegans in Parkinson's Disease Drug Discovery: Addressing an Unmet Medical Need

(2009) R. Nass et al.   MOLECULAR INTERVENTIONS

Preclinical drug trials in themdxmouse: Assessment of reliable and sensitive outcome measures

(2009) Christopher F. Spurney et al.   MUSCLE & NERVE

Treatments for muscular dystrophy: Increased treatment options for Duchenne and related muscular dystropies

(2008) D J Wells   GENE THERAPY

External pH influences the transcriptional profile of the carbonic anhydrase, CAH-4b in Caenorhabditis elegans

(2008) Rebecca A. Hall et al.   MOLECULAR AND BIOCHEMICAL PARASITOLOGY

Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy

(2008) Miranda D. Grounds et al.   NEUROBIOLOGY OF DISEASE

Free radicals and muscle fatigue: Of ROS, canaries, and the IOC

(2007) Michael B. Reid   FREE RADICAL BIOLOGY AND MEDICINE